Galen Institute

A not-for-profit health and tax policy research organization.

HHS Marches Forward To Enhance Drug Price Transparency

POSTED BY on .

Published on FORBES.com | President Donald Trump speaks during an event about prescription drug prices with Health and Human Services Secretary Alex Azar in the Rose Garden of the White House in Washington, Friday, May 11, 2018. (AP Photo/Carolyn Kaster) HHS Secretary Alex Azar has been almost singularly focused in delivering on the administration’s promises to increase transparency and … [Read more...] about HHS Marches Forward To Enhance Drug Price Transparency

The Left’s Utopian Health Care Promises

POSTED BY on .

Published on FORBES.com | Democrats have been pulling levers for decades to exert greater and greater government control over our health sector.  But the more government gets involved, the more dysfunctional the market becomes.  The left now contends that the mess can only be solved with a complete government takeover. They believe their moment has come. Americans … [Read more...] about The Left’s Utopian Health Care Promises

A Tale of Two Big (Medicare) Mistakes

POSTED BY on .

So here is a glimpse into one small part of the vast U.S. health care industry that shows the incredible difficulty government agencies have in setting accurate and fair payment rates for medical services, even when specifically directed by Congress to do so.  It offers a cautionary tale for those who would put the entire health care system under government control.  The players in … [Read more...] about A Tale of Two Big (Medicare) Mistakes

GOP May Outflank Bernie on Drug Price Controls

POSTED BY on .

Published on RealClearHealth.com | It wasn’t so long ago that Bernie Sanders (I-VT) comfortably occupied the left flank of health care policy. His Medicare For All bill was sufficiently costly, coercive and utopian to set him apart from the pack. Times have changed. When it comes to drug pricing, Bernie faces unexpected intruders on his left:  Republicans. In recent months, … [Read more...] about GOP May Outflank Bernie on Drug Price Controls